Accordingly, Menarini Group offers to HCPs and to the public a wide range of pharmaceutical products, both ethical and O.T.C. (Over The Counter), providing treatment solutions for different painful conditions.
As a result, Menarini Group recently introduced in Europe and several extra European Countries a new painkiller drug, enlarging its portfolio in the therapeutic area.
Moreover, in this area, the Company supports numerous clinical studies, carrying out constant updates to both physicians and patients.
With high medical-scientific information standards, Menarini Group actively supports HCPs in the correct communication with patients, playing a fundamental role in the successful management of their painful conditions.